Phio Pharmaceuticals(PHIO)

其他

Phio Pharmaceuticals(PHIO)05-09 05:05

$Phio Pharmaceuticals(PHIO)$ ARS Annual Report to Security Holders Accession Number: 0001683168-24-003112  Act: 34  Size: 1 MB 网页链接查看全文

季度财报

Phio Pharmaceuticals(PHIO)05-10 05:25

$Phio Pharmaceuticals(PHIO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-24-003175  Act: 34  Size: 2 MB 网页链接查看全文

招股说明书

Phio Pharmaceuticals(PHIO)05-18 04:55

$Phio Pharmaceuticals(PHIO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-003624  Act: 33  Size: 693 KB 网页链接查看全文

当期报告

Phio Pharmaceuticals(PHIO)07-13 04:35

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001683168-24-004800  Act: 34  Size: 593 KB 网页链接查看全文

发行公告

Phio Pharmaceuticals(PHIO)07-24 18:05

$Phio Pharmaceuticals(PHIO)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001123292-24-000200  Act: 33  Size: 10 KB 网页链接查看全文

股东委托书协议

Phio Pharmaceuticals(PHIO)05-09 05:05

$Phio Pharmaceuticals(PHIO)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-24-003113  Act: 34  Size: 2 MB 网页链接查看全文

当期报告

Phio Pharmaceuticals(PHIO)06-22 04:55

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001683168-24-004417  Act: 34  Size: 397 KB 网页链接查看全文

其他

Phio Pharmaceuticals(PHIO)05-21 05:05

$Phio Pharmaceuticals(PHIO)$ RW Registration Withdrawal Request Accession Number: 0001683168-24-003696  Act: NE  Size: 8 KB 网页链接查看全文

增发股票注册声明

Phio Pharmaceuticals(PHIO)05-21 05:05

$Phio Pharmaceuticals(PHIO)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-24-003698  Act: 33  Size: 692 KB 网页链接查看全文

持股变动声明

Phio Pharmaceuticals(PHIO)06-11 05:05

$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004089  Size: 4 KB 网页链接查看全文

只抄右侧底2023-10-11 23:33

$Phio Pharmaceuticals(PHIO)$ $Tempest Therapeutics(TPST)$ 模仿秀。居然在2.2加仓还能2.5出来我也是醉了，再进$Blue Star Foods(BSFC)$ ,既然是玩垃圾股那就一个个玩过来。这个才5500股大家看看就好，不建议乱来。查看全文

产业链观察2023-02-10 21:56

#药闻简讯# 2023年2月10日，临床阶段生物技术公司$Phio Pharmaceuticals(PHIO)$ 今天宣布，一个独立的数据监测委员会 (DMC) 完成了对公司用于治疗晚期黑色素瘤的 PH-762 1b 期临床试验的中期安全数据的预指定审查。该试验正在欧洲最大的癌症中心之一Gustave Roussy研究所（法国Villejuif）进行。PH...查看全文

牛唐2022-04-14 11:31

$Phio Pharmaceuticals(PHIO)半个月，150%+的收益。$百度(BIDU)$ $叮咚买菜(DDL)$ $理想汽车(LI)$查看全文

牛唐2022-04-13 21:24

$Phio Pharmaceuticals(PHIO)$ 150%+的收益。$蔚来(NIO)$ $阿里巴巴(BABA)$查看全文

牛唐2021-04-13 17:17

$Phio Pharmaceuticals(PHIO)$ 虎口夺食。$哔哩哔哩(BILI)$ $快手-W(01024)$查看全文

牛唐2021-04-13 12:13

医药板块观察（2021.04.12）
本期内容提示：
1、一大波核心仓位出现建仓机会，优先考虑哪些？
2、又一只有翻倍潜力的成长股临近理想建仓区；
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错，可否追涨？
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文

似云似水2021-03-11 21:25

$Phio Pharmaceuticals(PHIO)$ 有点意思了 开盘后但愿能挺住查看全文

Replix锐璞美股2021-03-01 21:16

$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文

晚安海绵宝宝2021-02-18 16:34

$Phio Pharmaceuticals(PHIO)$看个7不过分吧查看全文

Replix锐璞美股2021-02-18 14:08

$Phio Pharmaceuticals(PHIO)$ 公司增发完毕，看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文

持股变动声明

$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-010384  Size: 5 KB 网页链接

超过5%股东持股披露「修订」

$Phio Pharmaceuticals(PHIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-22-006700  Act: 34  Size: 66 KB 网页链接

超过5%股东持股披露「修订」

$Phio Pharmaceuticals(PHIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-22-000373  Act: 34  Size: 77 KB 网页链接

其他

$Phio Pharmaceuticals(PHIO)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-001484  Act: 34  Size: 3 KB 网页链接

当期报告

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-21-005423  Act: 34  Size: 260 KB 网页链接

季度财报

$Phio Pharmaceuticals(PHIO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-21-005420  Act: 34  Size: 3 MB 网页链接

持股变动声明

$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-051759  Size: 4 KB 网页链接

当期报告

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-21-003479  Act: 34  Size: 259 KB 网页链接

季度财报

$Phio Pharmaceuticals(PHIO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-21-003476  Act: 34  Size: 3 MB 网页链接

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, item 5.07 Accession Number: 0001683168-21-002649  Act: 34  Size: 27 KB 网页链接